Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Report ID | 216641 |
Drug Identification Number | 02382636 |
Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION USP |
Common or Proper name | HYDROMORPHONE HYDROCHLORIDE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 x 5mL vial |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-08 |
Actual start date | |
Estimated end date | |
Actual end date | 2024-02-14 |
Shortage status | Avoided shortage |
Updated date | 2024-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-15 | French | Compare |
v3 | 2024-02-15 | English | Compare |
v2 | 2024-01-19 | French | Compare |
v1 | 2024-01-19 | English | Compare |
Showing 1 to 4 of 4